Observational studyProstate cancer and prostatic diseases2023

Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases.

Martin W Schoen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.